Evidence map›Paper›PMID 28975502›Full record

ArticleNeurotoxicity research2018

L-Serine-Mediated Neuroprotection Includes the Upregulation of the ER Stress Chaperone Protein Disulfide Isomerase (PDI).

R A Dunlop, J T Powell, J S Metcalf, G J Guillemin, P A Cox

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03580616 (Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03580616 phase2terminatednot on this map

Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis: A Phase IIa Study

TypeinterventionalSponsorElijah W. StommelRan2018 to 2022Enrolled43ConditionsAmyotrophic Lateral Sclerosis (ALS)ArmsL-Serine
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND.Journal of neuropathology and experimental neurology · 2020
    Article
  13. L-serine: a neglected amino acid with a potential therapeutic role in diabetes.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2019
    Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

R A DunlopBrain Chemistry Labs, Institute for Ethnomedicine, Jackson Hole, WY, USA.
J T PowellBrain Chemistry Labs, Institute for Ethnomedicine, Jackson Hole, WY, USA.
J S MetcalfBrain Chemistry Labs, Institute for Ethnomedicine, Jackson Hole, WY, USA.
G J GuilleminNeuroinflammation Group, MND and Neurodegenerative Diseases Research Center, Macquarie University, Sydney, Australia.
P A CoxBrain Chemistry Labs, Institute for Ethnomedicine, Jackson Hole, WY, USA. paul@ethnomedicine.org.
Institute for EthnoMedicine · USMacquarie University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The unfolded protein response (UPR) is a highly evolutionarily conserved response to endoplasmic reticulum (ER) stress, which functions to return cells to homeostasis or send them into apoptosis, depending on the degree of cellular damage. β-N-methylamino-L-alanine (L-BMAA) has been shown to induce ER stress in a variety of models and has been linked to several types of neurodegenerative disease including Guamanian amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC). L-Serine, an amino acid critical for cellular metabolism and neurological signaling, has been shown to be protective against L-BMAA-induced neurotoxicity in both animal and cell culture models. While the mechanisms of L-BMAA neurotoxicity have been well characterized, less is known about L-serine neuroprotection. We recently reported that L-serine and L-BMAA generate similar differential expression profiles in a human ER stress/UPR array, despite L-serine being neuroprotective and L-BMAA being linked to neurodegenerative disease. Here, we further investigate the mechanism(s) of L-serine-induced UPR dysregulation by examining key genes and proteins in the ER stress/UPR pathways. We report that L-serine selectively increased protein disulfide isomerase (PDI) protein translation, an ER chaperone involved in refolding misfolded proteins, suggesting it may be modulating the UPR to favor recovery from ER stress. This constitutes a new mechanism for L-serine-mediated neuroprotection and has implications for its use as a therapy for neurodegenerative illnesses.

Indexed as

Activating Transcription Factor 4Amino Acids, DiaminoApoptosisCaspase 3Cell Line, TumorCell SurvivalCyanobacteria ToxinsEndoplasmic Reticulum StressHumansL-Lactate DehydrogenaseNerve DegenerationNeuroblastomaNeuroprotectionProtein Disulfide-IsomerasesRNA, MessengerSerineActivating Transcription Factor 4Amino Acids, DiaminoATF4 protein, humanbeta-N-methylamino-L-alanineCaspase 3Cyanobacteria ToxinsL-Lactate DehydrogenaseProtein Disulfide-IsomerasesRNA, MessengerSerineX-Box Binding Protein 1XBP1 protein, humanER stressL-BMAAL-SerineNeuroprotectionPDIUnfolded protein response

Identifiers

PMID28975502
OpenAlexW2762668088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.